Status:
COMPLETED
Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults
Lead Sponsor:
Ipsen
Conditions:
Diarrhea
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate whether Smecta® is more effective than placebo with respect to time to recovery following an acute diarrhoea episode.
Eligibility Criteria
Inclusion
- Acute diarrhoea episode defined as at least 3 watery stools per day for 48 hours or less
- Patient with, usually, normal bowel habits, i.e. at least 3 stools per week and no more than 3 stools per day
Exclusion
- Gross blood, pus in the stools
- Fever \>39ºC
- Other episode of acute watery diarrhoea within the last 30 days
- History of chronic diarrhoea or motor diarrhoea
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
346 Patients enrolled
Trial Details
Trial ID
NCT00276328
Start Date
January 1 2005
End Date
July 1 2006
Last Update
April 28 2020
Active Locations (31)
Enter a location and click search to find clinical trials sorted by distance.
1
Cabinet Médical, 50 rue Tata
Casablanca, Morocco, 20000
2
Cabinet Medical, 17 Boulevard Bir Anzaran
Casablanca, Morocco, 20200
3
Cabinet Médical, 12 rue Reaumur
Casablanca, Morocco, 20200
4
Cabinet Médical, 94 boulevard du 11 janvier
Casablanca, Morocco, 20200